Collegium Pharmaceutical, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Collegium Pharmaceutical, Inc. (COLL) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -1.90% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2023-02-23
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -1.90%.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -3.90%, a 454.55% decline from fiscal 2020.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2020 was 1.10%.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2019 was -1.40%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2022-12-31 | -1.90% 10-K · filed 2023-02-23 | |
| 2021-12-31 | -3.90% 10-K · filed 2023-02-23 | |
| 2020-12-31 | 1.10% 10-K · filed 2023-02-23 | -1.85% 10-K · filed 2021-02-25 |
| 2019-12-31 | -1.40% 10-K · filed 2022-02-24 | 3.24% 10-K · filed 2020-02-27 |
| 2018-12-31 | -2.51% 10-K · filed 2021-02-25 | 2.51% 10-K · filed 2019-02-27 |
| 2017-12-31 | 2.49% 10-K · filed 2020-02-27 | |
| 2016-12-31 | 1.45% 10-K · filed 2019-02-27 | |
| 2015-12-31 | 1.70% 10-K · filed 2018-03-07 | |
| 2014-12-31 | 0.17% 10-K · filed 2017-03-10 | |
| 2013-12-31 | 0.01% 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |